Seegene Launches Innovative mpox Detection Assays for Research

Seegene Unveils Advanced mpox Detection Solutions

In a remarkable advancement in public health research, Seegene Inc. has announced the launch of its new Novaplex™ MPXV/OPXV plus Assay. This cutting-edge research-use-only (RUO) assay is engineered to specifically target and detect the mpox virus, particularly Clade I, known for its higher transmission rates and associated mortality risks compared to Clade II.

New Assay Targets for Enhanced Accuracy

Unique Features of the Novaplex™ Assay

The Novaplex™ MPXV/OPXV plus Assay is designed to identify non-variola Orthopoxvirus (OPXV) alongside the mpox virus (MPVX). Notably, it provides precise confirmation of MPXV Clade I infections, offering vital assistance to healthcare professionals in their research endeavors, especially during this current challenge of mpox's spread.

Alignment with International Health Standards

In accordance with the World Health Organization's (WHO) target product profiles, Seegene's latest assay promises accurate viral strain detection. By adhering to these guidelines, the assay aids in ensuring that healthcare professionals can identify emerging mpox cases accurately, thereby supporting global health efforts effectively.

Global Health Response Initiatives

Seegene has demonstrated a proactive approach in addressing the recent global public health emergency related to mpox. The WHO has classified the mpox outbreak as a Public Health Emergency of International Concern (PHEIC), prompting Seegene to develop two new assays tailored for urgent global needs.

The Novaplex™ MPXV/OPXV Assay (RUO) is not alone in its capacity; there’s also the Novaplex™ HSV-1&2/VZV/MPXV Assay (RUO), which simultaneously detects four viruses, including mpox and several strains of the herpes virus. Both assays align with the WHO's criteria, ensuring that researchers have the tools necessary to address the virus's spread comprehensively.

Commitment to Combatting mpox Spread

Daniel Shin, Seegene’s Executive Vice-President and Chief Global Sales and Marketing Officer, expressed the company’s dedication to combatting the mpox virus. "As we witness the persistent spread of mpox, we have intensified our efforts to develop RUO assays that fulfill the urgent research demands of affected nations,” he said.

The Broader Impact of mpox

To provide context on the ongoing crisis, the Africa Centres for Disease Control and Prevention reports alarming numbers from January to September 2024, with over 24,851 suspected and 5,549 confirmed cases, which highlights the urgent need for effective detection tools.

Notably, mpox is expanding beyond its traditional regions, with cases emerging in various countries, including Sweden, Pakistan, and Thailand. This underscores the global nature of the threat posed by mpox, making advanced detection solutions more crucial than ever.

About Seegene

Seegene brings over 23 years of expertise in research, development, and manufacturing focused on multiplex PCR technologies. Their capabilities gained widespread recognition during the pandemic, enabling them to deliver over 340 million COVID-19 tests to more than 100 nations. By allowing simultaneous testing of multiple pathogens, Seegene’s technology is vital for answering global health challenges.

Frequently Asked Questions

What is the Novaplex™ MPXV/OPXV plus Assay?

The Novaplex™ MPXV/OPXV plus Assay is a new PCR assay designed to detect mpox Clade I and other Orthopoxviruses to support research efforts globally.

Why is mpox Clade I concerning?

MPXV Clade I poses higher transmission and mortality risks compared to other variants, making accurate detection critically important.

How does Seegene's assay help healthcare professionals?

By adhering to WHO standards and accurately diagnosing infections, the assay provides healthcare professionals necessary insights for managing outbreaks.

What other products have been developed by Seegene?

In addition to the new mpox assays, Seegene also offers assays that test for herpes simplex viruses, significantly broadening the scope of their research utility.

What is Seegene's experience in diagnostics?

With decades of experience, Seegene is recognized for its advanced PCR technology and for delivering millions of tests to tackle global health crises effectively.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.